AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takemura, H.
Right arrow Articles by Nakashima, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takemura, H.
Right arrow Articles by Nakashima, H.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, December 2003, p. 3996-3997, Vol. 47, No. 12
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.12.3996-3997.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

LETTER TO THE EDITOR

Susceptibilities of Fluoroquinolone-Resistant Haemophilus parainfluenzae Isolates from Japanese Patients with Respiratory Infections to Five Fluoroquinolones and Other Antimicrobial Agents


   LETTER
Top
 Letter
References
 
Respiratory tract infections remain a common cause of morbidity and mortality worldwide, and Haemophilus spp. have been the important pathogens causing respiratory tract infections (2, 3). Haemophilus parainfluenzae is one of the pathogens that are frequently isolated from respiratory specimens, but the clinical isolates are usually neglected as indigenous bacteria of the human respiratory tract. However, recent case reports have indicated that H. parainfluenzae might also be the causative organism of certain respiratory diseases, such as acute pneumonia (4, 7). We have focused on this bacterium by studying its prevalence in patients, as well as the antimicrobial susceptibilities of the clinical isolates. Furthermore, we identified some fluoroquinolone-resistant strains of H. parainfluenzae (FRHP) in our collection.

Respiratory specimens (e.g., sputum, pharyngeal swabs, and tonsillar swabs) were collected from patients visiting the outpatient departments of 382 facilities all over Japan in 1998 to 2000. H. influenzae (1,213 strains), H. parainfluenzae (920 strains), H. haemolyticus (232 strains), and H. parahaemolyticus (111 strains) were isolated from the samples collected in the 3 years. The MICs of some antimicrobial agents, including levofloxacin, were determined for all of the strains by the NCCLS standard broth microdilution method (5). Ampicillin was purchased from Wako Chemicals (Osaka, Japan), and all other antimicrobial agents were kindly provided by the corresponding manufacturers. We determined the fluoroquinolone-resistant strains of Haemophilus spp. with the NCCLS breakpoint of levofloxacin, >2 µg/ml (6). The numbers of FRHP isolates were 2 (2.4%), 16 (3.6%), and 13 (3.0%) in 1998, 1999, and 2000, respectively, while only one or two fluoroquinolone-resistant strains of the other Haemophilus spp. were isolated. The distributions of drug MICs for H. parainfluenzae, 20 fluoroquinolone-susceptible strains of H. parainfluenzae (FSHP), and 30 FRHP isolates are summarized in Table 1. All five fluoroquinolones exhibited excellent antimicrobial activity against FSHP (MICs for 90% of the strains tested [MIC90s], <=0.015 to 0.06 µg/ml), whereas each MIC90 of fluoroquinolones for FRHP was more than 100-fold higher than that that for FSHP. Sitafloxacin exhibited a clearly lower MIC90 (1 µg/ml) than did the other fluoroquinolones. The susceptibilities of FRHP to other, nonfluoroquinolone antimicrobial agents were similar to those of FSHP, while two FRHP isolates exhibited lower susceptibilities to ampicillin (MIC, >32 µg/ml).


View this table:
[in this window]
[in a new window]
  		TABLE 1. Distribution of the MICs of five fluoroquinolones and four nonfluoroquinolones for FSHP and FRHPa

 
To our knowledge, only a few studies previously examined the drug susceptibility of H. parainfluenzae. The recently reported surveillance studies in Europe (2) and the United States (3) indicated that most H. parainfluenzae isolates were susceptible to levofloxacin and other fluoroquinolones. This is the first report regarding clinical isolates of FRHP. It is conceivable that the fluoroquinolone resistance of FRHP described in this report is caused by genetic mutations in the gyrA and/or the parC gene which likely occur in some other bacteria, such as Streptococcus pneumoniae and H. influenzae (1, 8). This bacterial resistance might be related to the selective pressure derived from the prevalent use of fluoroquinolones in Japan (8). Careful monitoring of changes in the drug susceptibility pattern of H. parainfluenzae, as well as those of many other pathogens, is important.

(This study was previously presented in part [42nd Intersci. Conf. Antimicrob. Agents Chemother., abstr. C2-1994, p. 124].)


   ACKNOWLEDGMENTS
 
We thank Shinsuke Matsuki, Suntory Co., Ltd., for assistance with the collection of strains and Intetsu Kobayashi, Mitsubishi Kagaku Bio-Clinical Laboratories, for helpful assistance and suggestions.


   REFERENCES
Top
 Letter
 References
 

  1. Biedenbach, D. J., and R. N. Jones. 2000. Fluoroquinolone-resistant Haemophilus influenzae: frequency of occurrence and analysis of confirmed strains in the SENTRY antimicrobial surveillance program (North and Latin America).Diagn. Microbiol. Infect. Dis. 36:255-259.[CrossRef][Medline]
  2. Felmingham, D. 2000. Respiratory pathogens: assessing resistance patterns in Europe and the potential role of grepafloxacin as treatment of patients with infections caused by these organisms. J. Antimicrob. Chemother. 45(Topic T2):1-8.[Abstract]
  3. Hoban, D. J., S. K. Bouchillon, J. L. Johnson, G. G. Zhanel, D. L. Butler, L. A. Miller, J. A. Poupard, and The Gemifloxacin Surveillance Study Research Group. 2001. Comparative in vitro activity of gemifloxacin, ciprofloxacin, levofloxacin and ofloxacin in a North American surveillance study. Diagn. Microbiol. Infect. Dis. 40:51-57.[CrossRef][Medline]
  4. Mitchell, J. L., and S. L. Hill. 2000. Immune response to Haemophilus parainfluenzae in patients with chronic obstructive lung disease. Clin. Diagn. Lab. Immunol. 7:25-30.[Abstract/Free Full Text]
  5. NCCLS.2001 . Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 5th ed. NCCLS document M7-A5. NCCLS, Wayne, Pa.
  6. NCCLS.2001 . Performance standards for antimicrobial susceptibility testing, 11th informational supplement. NCCLS document M 100-S11. NCCLS, Wayne, Pa.
  7. Pillai, A., J. L. Mitchell, S. L. Hill, and R. A. Stockley. 2000. A case of Haemophilus parainfluenzae pneumonia. Thorax 55:623-624.[Abstract/Free Full Text]
  8. Yokota, S., K. Sato, O. Kuwahara, S. Habadera, N. Tsukamoto, H. Ohuchi, H. Akizawa, T. Himi, and N. Fujii. 2002. Fluoroquinolone-resistant Streptococcus pneumoniae strains occur frequently in elderly patients in Japan. Antimicrob. Agents Chemother. 46:3311-3315.[Abstract/Free Full Text]
Hiromu Takemura*
Shigemi Terakubo
Hiroyuki Yamamoto
Jingoro Shimada
Hideki Nakashima
Department of Microbiology
St. Marianna University School of Medicine
2-16-1 Sugao Miyamae-ku
Kawasaki 216-8511, Japan

Keiji Kanemitsu
Department of Molecular Diagnostics
Tohoku University Graduate School of Medicine
Sendai, Japan

* Phone: 81 (44) 977-8111, Fax: 81 (44) 977-7818, E-mail: takeh{at}marianna-u.ac.jp>

Antimicrobial Agents and Chemotherapy, December 2003, p. 3996-3997, Vol. 47, No. 12
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.12.3996-3997.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takemura, H.
Right arrow Articles by Nakashima, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takemura, H.
Right arrow Articles by Nakashima, H.

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS